Skip to main content

User account menu

  • Log in
  • Join ISSUP

Languages

  • English
  • Français
  • Português
  • Español
  • العربية
  • Pусский

Main navigation

  • About ISSUP

    • 10 Years of ISSUP
    • ISSUP Rationale
    • Membership
      • Membership Criteria
      • Code of Ethics
      • Who is ISSUP for?
    • News
      • Newsletters
    • ISSUP Events
    • International Partners
    • Governance
    • ISSUP Scientific Council
    • Friends of ISSUP (USA)
    • ISSUP Awards
      • Evidence-Based Award
      • Local Initiative Award
      • Services Award
      • Excellence in Training Provision
      • Outstanding Contribution to ISSUP Award
    • In Memoriam
    • Acknowledgements
    • ISSUP Website Guides
    • Contact ISSUP
    • FAQs - Frequently Asked Questions
    • Donate to ISSUP
  • Professional Development

    • Online Learning Hub
      • How to Register
      • UTC Self Led Courses
    • Universal Curricula (UC)
      • Universal Prevention Curriculum
      • Universal Treatment Curriculum
      • Universal Recovery Curriculum
    • Resources
      • Drug Data Hub
      • Glossary
      • The ISSUP Exchange
      • ISSUP Webinars
      • IEP
      • INEP Plus
      • Prevention Insights Video Series
      • Prevention Lists
      • Recovery Support
      • Quality in Treatment
      • ICAP certification
      • HealthEKnowledge
    • Jobs and Opportunities
  • Knowledge Share

    • Search in the Knowledge Share
    • ADDICTOLOGY Journal
      • Latest Issue
  • National Chapters

    • Africa
      • ISSUP Botswana
      • ISSUP Côte d’Ivoire
      • ISSUP Egypt
      • ISSUP Ethiopia
      • ISSUP The Gambia
      • ISSUP Ghana
      • ISSUP Kenya
      • ISSUP Liberia
      • ISSUP Mauritius
      • ISSUP Morocco
      • ISSUP Namibia
      • ISSUP Nigeria
      • ISSUP South Africa
      • ISSUP Tanzania
      • ISSUP Togo
      • ISSUP Uganda
      • ISSUP Zambia
    • The Americas
      • ISSUP Argentina
      • ISSUP The Bahamas
      • ISSUP Barbados
      • ISSUP Brazil
      • ISSUP Canada
      • ISSUP Chile
      • ISSUP Colombia
      • ISSUP Ecuador
      • ISSUP El Salvador
      • ISSUP Guatemala
      • ISSUP Mexico
      • ISSUP Panama
      • ISSUP Paraguay
      • ISSUP Peru
      • ISSUP United States
    • Asia
      • ISSUP Afghanistan
      • ISSUP Bangladesh
      • ISSUP India
      • ISSUP Indonesia
      • ISSUP Kazakhstan
      • ISSUP Korea
      • ISSUP Lebanon
      • ISSUP Malaysia
      • ISSUP in Pakistan
      • ISSUP Philippines
      • ISSUP Qatar
      • ISSUP Singapore
      • ISSUP Sri Lanka
      • ISSUP Thailand
      • ISSUP Türkiye
      • ISSUP United Arab Emirates
      • ISSUP Uzbekistan
      • ISSUP Vietnam
    • Europe
      • ISSUP Bosnia & Herzegovina
      • ISSUP Czech Republic
      • ISSUP Greece
      • ISSUP Italy
      • ISSUP Spain
      • ISSUP Ukraine
      • ISSUP United Kingdom
    • Oceania
      • ISSUP Australia
      • ISSUP Fiji
      • ISSUP New Zealand
    • How to Become a National Chapter
    • ISSUP National Chapters' Advisory Committee
    • ISSUP National Chapter Spotlight
  • Events

    • Search through all events
    • ISSUP Events
      • ISSUP 2026
      • Indonesia 2025
      • Thessaloniki 2024
      • Buenos Aires 2023
      • Manila 2022
      • Abu Dhabi 2022
      • Virtual 2021
      • Africa 2020
      • Vienna 2019
      • Nairobi 2018
      • Cancún 2017
      • Campinas 2016
      • Bangkok 2015
  • Networks

    • A–Z
  • My ISSUP

    • Member Directory
    • Apply for membership

BRIXADI

Compare Brixadi vs. Sublocade dosing, injection schedules, half-life, side effects, storage, induction, REMS requirements and key treatment differences.

Moderators

Profile picture for user help
Benjamin Zohar, NCACIP
Intervention New York
DiscussionsFilesImagesVideosLinksEventsKnowledge ShareAll
Benjamin Zohar, NCACIP

Sublocade vs. Suboxone: Injection vs. Film, Doses, Withdrawal & Key Differences

Benjamin Zohar, NCACIP - 27 September 2026
Sublocade vs. Suboxone comparison showing monthly buprenorphine injection versus daily buprenorphine-naloxone film, including dosing, administration, REMS, take-home access, and dose flexibility.
Sublocade and Suboxone both use buprenorphine to treat opioid use disorder, but Sublocade is a long-acting monthly injection while Suboxone is a self-administered buprenorphine/naloxone film. This guide explains dosing, induction, withdrawal, side effects and the practical differences between them.
Translations
Español
  • Read more about Sublocade vs. Suboxone: Injection vs. Film, Doses, Withdrawal & Key Differences
  • ISSUP members can join Networks to comment – Sign in or become a member
Benjamin Zohar, NCACIP

How Long Does Alcohol Stay in Urine? EtG, EtS & Detection Windows

Benjamin Zohar, NCACIP - 27 September 2026
Infographic showing how long alcohol stays detectable in urine, comparing urine ethanol, EtG, and EtG plus EtS detection windows from a few hours to about 5 days.
Alcohol itself is detectable in urine for a relatively short period, but metabolites such as EtG and EtS may remain measurable for days. Learn how urine alcohol testing works, what an 80-hour EtG test means, and why detection windows vary.
  • Read more about How Long Does Alcohol Stay in Urine? EtG, EtS & Detection Windows
  • ISSUP members can join Networks to comment – Sign in or become a member
Benjamin Zohar, NCACIP

Brixadi vs. Suboxone: Doses, Conversion, Withdrawal & Key Differences

Benjamin Zohar, NCACIP - 27 September 2026
Brixadi and Suboxone both deliver buprenorphine for opioid use disorder, but Brixadi is a weekly or monthly healthcare-administered injection while Suboxone is a daily buprenorphine/naloxone film. This guide explains FDA switching doses, induction, withdrawal, side effects and key practical differences.
  • Read more about Brixadi vs. Suboxone: Doses, Conversion, Withdrawal & Key Differences
  • ISSUP members can join Networks to comment – Sign in or become a member
Benjamin Zohar, NCACIP

Sublocade vs. Vivitrol: Buprenorphine vs. Naltrexone, Detox, Side Effects & Key Differences

Benjamin Zohar, NCACIP - 27 September 2026
Sublocade vs. Vivitrol comparison showing buprenorphine as a partial opioid agonist and naltrexone as an opioid antagonist, with differences in monthly dosing, detox requirements, and overdose considerations.
Sublocade and Vivitrol are once-monthly injections used in opioid use disorder treatment, but they work very differently. Sublocade contains the partial opioid agonist buprenorphine, while Vivitrol contains the opioid antagonist naltrexone and requires patients to be opioid-free before treatment.
  • Read more about Sublocade vs. Vivitrol: Buprenorphine vs. Naltrexone, Detox, Side Effects & Key Differences
  • ISSUP members can join Networks to comment – Sign in or become a member
Benjamin Zohar, NCACIP

Brixadi vs. Sublocade: Doses, Side Effects, REMS, Half-Life & Key Differences

Benjamin Zohar, NCACIP - 27 September 2026
Brixadi vs Sublocade comparison showing dosing schedules, strengths, half-life, storage and injection differences
Brixadi and Sublocade are extended-release buprenorphine injections used for opioid use disorder, but they differ in dosing frequency, strengths, half-life, storage and treatment flexibility. This comparison explains the practical differences using current FDA prescribing information.
  • Read more about Brixadi vs. Sublocade: Doses, Side Effects, REMS, Half-Life & Key Differences
  • ISSUP members can join Networks to comment – Sign in or become a member

Upcoming Events

There aren't any upcoming events
All Events
Contact Us

Stay Connected

Newsletter

Subscribe to the ISSUP Newsletter

ISSUP is funded by the U.S. Department of State via the Bureau of International Narcotics and Law Enforcement Affairs (INL). INL works to keep Americans safe by countering crime, illegal drugs, and instability abroad.

Copyright © International Society of Substance Use Professionals Privacy Policy